Prostate cancer–Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancer

Autor: Lucy McGeagh, Luke A. Robles, Raj Persad, Edward Rowe, Amit Bahl, Jonathan Aning, Anthony Koupparis, Paul Abrams, Claire Perks, Jeffrey Holly, Lyndsey Johnson, Constance Shiridzinomwa, Amarnath Challapalli, Ellie Shingler, Hilary Taylor, Jon Oxley, Meda Sandu, Richard M. Martin, J. Athene Lane

Publikováno v: Pilot and Feasibility Studies, Vol 8, Iss 1, Pp 1-12 (2022)

Abstract Background Evidence from observational studies have shown that moderate intensity physical activity can reduce risk of progression and cancer-specific mortality in participants with prostate cancer. Epidemiological studies have also shown pa

Externí odkaz: https://doaj.org/article/cdb6ac72f29a483d93ebd18101837518

Prostate cancer survivors’ preferences on the delivery of diet and lifestyle advice: a pilot best-worst discrete choice experiment

Autor: Luke A. Robles, Stuart J. Wright, Lucy Hackshaw-McGeagh, Ellie Shingler, Constance Shiridzinomwa, J. Athene Lane, Richard M. Martin, Sorrel Burden

Publikováno v: Pilot and Feasibility Studies, Vol 6, Iss 1, Pp 1-9 (2020)

Abstract Background Lifestyle factors, including diet and physical activity, are associated with prostate cancer progression and mortality. However, it is unclear how men would like lifestyle information to be delivered following primary treatment. T

Externí odkaz: https://doaj.org/article/7479102c73464a29b7514f58e096779c

Dietary restriction during the treatment of cancer: results of a systematic scoping review

Autor: Ellie Shingler, Rachel Perry, Alexandra Mitchell, Clare England, Claire Perks, Georgia Herbert, Andy Ness, Charlotte Atkinson

Publikováno v: BMC Cancer, Vol 19, Iss 1, Pp 1-15 (2019)

Abstract Background Diets that restrict energy or macronutrient intake (e.g. fasting/ketogenic diets (KDs)) may selectively protect non-tumour cells during cancer treatment. Previous reviews have focused on a subset of dietary restrictions (DR) or ha

Externí odkaz: https://doaj.org/article/aa6768cb9fa2490f81e8b355299f38e6

Dietary management for people with an ileostomy: a scoping review

Autor: Tom M Lander, Clare England, Aidan Searle, Ellie Shingler, Rachel Perry, Charlotte Atkinson, Alexandra Mitchell

Publikováno v: Mitchell, A, England, C Y, Perry, R E, Lander, T M, Shingler, E, Searle, A J & Atkinson, C 2021, ' Dietary management for people with an ileostomy : A scoping review ', JBI Evidence Synthesis, vol. 19, no. 9, pp. 2188-2306 . https://doi.org/10.11124/JBIES-20-00377

OBJECTIVE The objective of this review was to identify and map the evidence for oral dietary management of ileostomies. INTRODUCTION Dietary advice is commonly provided for ileostomy management but can be inconsistent, conflicting, and inadequate. Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7da61ee2d279bdec9ac7ab83f17f57
https://doi.org/10.11124/jbies-20-00377

A feasibility randomised controlled trial of short-term fasting prior to CAPOX chemotherapy for stage 2/3 colorectal cancer: SWiFT protocol

Autor: Andy R Ness, Charlotte Atkinson, Georgia Herbert, Claire M Perks, Ellie Shingler

Publikováno v: Pilot and Feasibility Studies, Vol 5, Iss 1, Pp 1-7 (2019)
Pilot and Feasibility Studies
Shingler, E, Perks, C, Herbert, G, Ness, A & Atkinson, C 2019, ' A Feasibility Randomised Controlled Trial of Short-Term Fasting Prior to CAPOX Chemotherapy for Stage 2/3 Colorectal Cancer : SWiFT Protocol ', Pilot and Feasibility Studies, vol. 5, 134 (2019) . https://doi.org/10.1186/s40814-019-0505-7

Background Capecitabine and oxaliplatin (CAPOX) chemotherapy is a standard treatment for stage 2/3 colorectal cancer. Treatment is associated with dose-limiting toxicities such as neutropenia, vomiting, diarrhoea, and stomatitis. Short-term fasting p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b8589b9da0a42261e22b24991ee8dd7
http://link.springer.com/article/10.1186/s40814-019-0505-7